Mid Cap Stocks At 52-Week Highs: Tuesday’s Full List
A small group of mid-sized companies hits new highs, raising questions about the quality of their gains.
Tenet Healthcare (THC) has gained 39.0% in a single month, a period where the S&P 500 returned just +3.4%. It is one of 8 Mid Cap stocks from the Russell 3000 trading at a 52-week high as of Tuesday.
The list is concentrated, with clusters appearing in the Health Care and Energy sectors. The central question is what separates a strong price from a strong business. Here are today’s names.
The Full List, Largest First
- The 52-Week-High List: 13 S&P 500 Names On Tuesday
- 25 Small Cap Stocks Just Made New 52-Week Highs
- S&P 500 Movers | Winners: TRGP, PODD, ULTA | Losers: COHR, LITE, STX
- Where The Selling Ran Deepest: 5 S&P 500 Stocks At 52-Week Lows
- 23 Stocks Hit 52-Week Lows On Tuesday
- 15 Large Cap Stocks Just Made New 52-Week Highs
Here are all 8 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| ROIV | $26.81 Bil | 3.1% | 6.0% | 9.8% | 215.4% |
| THC | $23.45 Bil | 2.1% | 4.1% | 39.0% | 57.1% |
| OVV | $18.21 Bil | 1.8% | 2.5% | 12.5% | 69.3% |
| PR | $18.15 Bil | 0.8% | 4.1% | 10.2% | 72.9% |
| DINO | $17.29 Bil | 0.7% | 11.9% | 6.5% | 122.9% |
| SEIC | $13.01 Bil | 1.4% | 2.2% | 7.6% | 22.7% |
| HALO | $12.39 Bil | 1.8% | 2.2% | 36.1% | 55.9% |
| DAR | $10.85 Bil | 1.0% | 9.6% | 7.6% | 119.2% |
Which of these highs are built on solid ground?
Not every new high is created equal. Tenet Healthcare (THC) supports its run with business performance: its revenue grew 9.4% over the last twelve months and its operating margin is 19.5%. The stock trades at 10.1 times trailing earnings.
Contrast that with the largest name on the list, Roivant Sciences (ROIV), with a market value of about $26.8 billion. Its revenue declined 67.6% over the last twelve months, and its operating margin is -18146.1%.
So what is the disciplined way to read this list?
A 52-week high signals strength, and strong stocks often continue to perform. But a price is not a verdict on a company’s health.
The disciplined move is to treat this list as a starting point for questions, not a finish line of answers. The essential work is to check whether the underlying business fundamentals, from revenue growth to margins, can earn the new, higher valuation.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks, which is the momentum that tends to have staying power.
New Highs Fade. Discipline Compounds
Some of the names on this list will keep setting highs for years, and some are at the top of their run right now. Sorting one from the other, name by name, every day, is the work most investors never keep up with.
That sorting is what the Trefis High Quality (HQ) Portfolio does systematically: about 30 quality businesses screened for the fundamentals that sustain a run, held with rules instead of excitement. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Use the high list for ideas; use the portfolio for the compounding.